Expression and function of the vitamin D receptor in malignant germ cell tumour of the testis

Anticancer Research

Volumn 32, Issue 1 PART 2, 2012, Pages 341-349

  Bremmer, Felix ^a   Thelen, P ^a   Pottek, T ^b   Behnes, C L ^a   Radzun, H J ^a   Schweyer, S ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^b Asklepios Westklinikum ^*  (Germany)

Author keywords

GADD45; Immunhistochemistry; PCR; TGCT; VDR; Vitamin D; Western blot

Indexed keywords

CYTOCHROME P450; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2; RECEPTOR INTERACTING PROTEIN 140; SILENCING MEDIATOR OF RETINOID AND THYROID HORMONE RECEPTOR; VITAMIN D; VITAMIN D RECEPTOR;

ADULT; CELL PROLIFERATION; CONFERENCE PAPER; GENE CONTROL; GERM CELL TUMOR; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TESTIS; TUMOR CELL LINE;

ADULT; BLOTTING, WESTERN; CELL PROLIFERATION; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; NEOPLASMS, GERM CELL AND EMBRYONAL; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, CALCITRIOL; RNA, MESSENGER; SIGNAL TRANSDUCTION; TESTICULAR NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; VITAMIN D;

EID: 84855985851     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (48)

1. Power DA, Brown RS, Brock CS, Payne HA, Majeed A and Babb P: Trends in testicular carcinoma in England and Wales, 1971-99. BJU Int 87: 361-365, 2001. (Pubitemid 32240850)
2. Zheng T, Holford TR, Ma Z, Ward BA, Flannery J and Boyle P: Continuing increase in incidence of germ-cell testis cancer in young adults: experience from Connecticut, USA, 1935-1992. Int J Cancer 65: 723-729, 1996. (Pubitemid 26127749)
3. Roelofs H, Mostert MC, Pompe K, Zafarana G, van Oorschot M, van Gurp RJ, Gillis AJ, Stoop H, Beverloo B, Oosterhuis JW, Bokemeyer C and Looijenga LH: Restricted 12p amplification and ras mutation in human germ cell tumors of the adult testis. Am J Pathol 157: 1155-1166, 2000.
4. Evans RM: The steroid and thyroid hormone receptor superfamily. Science 240: 889-895, 1988.
5. Kerner SA, Scott RA and Pike JW. Sequence elements in the human osteocalcin gene confer basal activation and inducible response to hormonal vitamin D3. Proc Natl Acad Sci USA 86: 4455-4459, 1989. (Pubitemid 19164573)
6. Haussler MR, Whitfield GK, Haussler CA, Hsieh JC, Thompson PD, Selznick SH, Dominguez CE and Jurutka PW: The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. J Bone Miner Res 13: 325-349, 1998. (Pubitemid 28146215)
7. 3. Proc Natl Acad Sci USA 78: 4990-4499, 1981.
8. Zhao X and Feldman D: Regulation of vitamin D receptor abundance and responsiveness during differentiation of HT-29 human colon cancer cells. Endocrinology 132: 1808-1814, 1993. (Pubitemid 23110559)
9. 3 and breast cancer. Aust N Z J Surg 54: 17-20, 1984.
10. 3 receptors and actions in human prostate cancer cell lines. Endocrinology 132: 1952-1960, 1993.
11. 3 1alpha-hydroxylase and vitamin D receptor expression in papillary thyroid carcinoma. J Histochem Cytochem 54: 355-361, 2006.
12. Norman AW, Roth J and Orci L: The vitamin D endocrine system: steroid metabolism, hormone receptors, and biological response (calcium binding proteins). Endocr Rev 3: 331-366, 1982.
13. Horlein AJ, Naar AM and Heinzel T: Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature 377: 397-404, 1995
14. Chen JD and Evans RM. A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature 377: 454-457, 1995.
15. Seeger M, Kraft R, Ferrell K, Bech-Otschir D, Dumdey R, Schade R, Gordon C, Naumann M and Dubiel W: A novel protein complex involved in signal transduction possessing similarities to 26S proteasome subunits. FASEB J 12: 469-478, 1998. (Pubitemid 28146526)
16. Schaefer L, Beermann ML and Miller JB: Coding sequence, genomic organization, chromosomal localization, and expression pattern of the signalosome component Cops2: the mouse homologue of Drosophila alien. Genomics 56: 310-316, 1999. (Pubitemid 29159911)
17. Mitschele T, Diesel B, Friedrich M, Meineke V, Maas RM, Gartner BC, Kamradt J, Meese E, Tilgen W and Reichrath J: Analysis of the vitamin D system in basal cell carcinomas (BCCs). Lab Invest 84: 693-702, 2004. (Pubitemid 38715470)
18. Stokoe D, Caudwell B, Cohen PT and Cohen P: The substrate specificity and structure of mitogen-activated protein (MAP) kinase-activated protein kinase-2. Biochem J 296 (Pt 3): 843-849, 1993. (Pubitemid 24008205)
19. Rouse J, Cohen P, Trigon S, Morange M, Alonso-Llamazares A, Zamanillo D, Hunt T and Nebreda AR: A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins. Cell 78: 1027-1037, 1994. (Pubitemid 24292330)
20. Fornace AJ Jr., Jackman J, Hollander MC, Hoffman-Liebermann B and Liebermann DA: Genotoxic-stress-response genes and growth-arrest genes. gadd, MyD, and other genes induced by treatments eliciting growth arrest. Ann NY Acad Sci 663: 139-153, 1992. (Pubitemid 23090532)
21. 3 in Ovarian Cancer Cells Mediated through the Induction of GADD45 via an Exonic Enhancer. J Biol Chem 278: 48030-48040, 2003.
22. Olert J, Wiedorn KH, Goldmann T, Kühl H, Mehraein Y, Scherthan H, Niketeghad F, Vollmer E, Müller AM and Müller-Navia J: HOPE fixation: a novel fixing method and paraffin-embedding technique for human soft tissues. Pathol Res Pract 197: 823-826, 2001. (Pubitemid 34036978)
23. Goldmann T, Vollmer E and Gerdes J: What's cooking? Detection of important biomarkers in HOPE-fixed, paraffin-embedded tissues eliminates the need for antigen retrieval. Am J Pathol 163: 2638-2640, 2003. (Pubitemid 37466505)
24. Remmele W and Stegner HE: Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue. Pathologe 8(3): 138-140, 1987.
25. Schweyer S, Bachern A, Bremmer F, Steinfelder HJ, Soruri A, Wagner W, Pottek T, Thelen P, Hopker WW, Radzun HJ and Fayyazi: Expression and function of protein phosphatase PP2A in malignant testicular germ cell tumours PP2A. J Pathol 213: 72-81, 2007.
26. Menezes RJ, Cheney RT, Husain A, Tretiakova M, Loewen G, Johnson CS, Jayaprakash V, Moysich KB, Salgia R and Reid ME: Vitamin D receptor expression in normal, premalignant, and malignant human lung tissue. Cancer Epidemiol Biomarkers Prev 17: 1104-1110, 2008.
27. Bareis P, Bises G, Bischof MG, Cross HS and Peterlik M: 25-Hydroxy-vitamin D metabolism in human colon cancer cells during tumour progression. Biochem Biophys Res Commun 285: 1012-1017, 2001. (Pubitemid 32918038)
28. Cross HS, Bareis P, Hofer H, Bischof MG, Bajna E, Kriwanek S, Bonner E and Peterlik M: 25-Hydroxyvitamin D (3)-1 alpha-hydroxylase and vitamin D receptor gene expression in human colonic mucosa is elevated during early cancerogenesis. Steroids 66: 287-292, 2001. (Pubitemid 32140906)
29. Pols HA, Birkenhager JC, Foekens JA and van Leeuwen JP: Vitamin D: a modulator of cell proliferation and differentiation. J Steroid Biochem Mol Biol 37: 873-876, 1990.
30. Colston KW, Chander SK, Mackay AG and Coombes RC. Effects of synthetic vitamin D analogues on breast cancer cell proliferation in vivo and in vitro. Biochem Pharmacol 44: 693-702, 1992.
31. Getzenberg RH, Light BW, Lapco PE, Konety BR, Nangia AK, Acierno JS, Dhir R, Shurin Z, Day RS and Trump DL: Vitamin D inhibition of prostate adenocarcinoma growth and metastasis in the Dunning rat prostate model system. Urology 50: 999-1006, 1997. (Pubitemid 28021128)
32. 3 receptor as a marker of human colon carcinoma cell line differentiation and growth inhibition. Cancer Res 53: 3712-3718, 1993.
33. Mantell DJ, Owens PE, Bundred NJ, Mawer EB and Canfield AE: 1 Alpha,25-dihydroxyvitamin D(3) inhibits angiogenesis in vitro and in vivo. Circ Res 87: 214-220, 2000. (Pubitemid 30626429)
34. Fornace AJ Jr., Jackman J, Hollander MC, Hoffman-Liebermann B and Liebermann DA: Genotoxic-stress-response genes and growth-arrest genes. GADD, MyD, and other genes induced by treatments eliciting growth arrest. Ann NY Acad Sci 663: 139-153, 1992. (Pubitemid 23090532)
35. 2-terminal kinase and p38 stress signaling resulting in apoptosis and senescence. Cancer Res 66: 8448-8454, 1992.
36. Tzelepi V, Grivas P, Kefalopoulou Z, Kalofonos H, Varakis JN and Sotiropoulou-Bonikou G: Expression of estrogen receptor co-regulators NCoR and PELP1 in epithelial cells and myofibroblasts of colorectal carcinomas: cytoplasmic translocation of NCoR in epithelial cells correlates with better (corrected) prognosis. Virchows Arch 454: 41-53, 2009.
37. Lee JW, Choi HS, Gyuris J, Brent R and Moore DD: Two classes of proteins dependent on either the presence or absence of thyroid hormone for interaction with the thyroid hormone receptor. Mol Endocrinol 9: 243-254, 1995.
38. Richardson KS and Zundel W: The emerging role of the COP9 signalosome in cancer. Mol Cancer Res 3: 645-653, 2005. (Pubitemid 43042994)
39. Kumar B, Koul S, Petersen J, Khandrika L, Hwa JS, Meacham RB, Wilson S and Koul HK: p38 mitogen-activated protein kinase-driven MAPKAPK2 regulates invasion of bladder cancer by modulation of MMP-2 and MMP-9 activity. Cancer Res 70: 832-841, 2010.
40. Xu L, Chen S and Bergan RC: MAPKAPK2 and HSP27 are downstream effectors of p38 MAP kinase-mediated matrix metalloproteinase type 2 activation and cell invasion in human prostate cancer. Oncogene 25: 2987-2998, 2006. (Pubitemid 43780463)
41. Kotlyarov A, Yannoni Y, Fritz S, Laass K, Telliez JB, Pitman D, Lin LL and Gaestel M: Distinct cellular functions of MK2. Mol Cell Biol 22: 4827-4835, 2002. (Pubitemid 34620417)
42. Bises G, Kallay E, Weiland T, Wrba F, Wenzl E, Bonner E, Kriwanek S, Obrist P and Cross HS: 25-hydroxyvitamin D31alpha-hydroxylase expression in normal and malignant human colon. J Histochem Cytochem 52: 985-989, 2004. (Pubitemid 38857163)
43. Deeb KK, Trump DL and Johnson CS: Vitamin D signalling pathways in cancer: potential for anticancer therapeutics. Nat Rev Cancer 7: 684-700, 2007. (Pubitemid 47327412)
44. Cross HS, Bises G, Lechner D, Manhardt T and Kallay E: The Vitamin D endocrine system of the gutits possible role in colorectal cancer prevention. J Steroid Biochem Mol Biol 97: 121-128, 2005. (Pubitemid 41546221)
45. Albertson DG, Ylstra B, Segraves R, Collins C, Dairkee SH, Kowbel D, Kuo WL, Gray JW and Pinkel D: Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene. Nat Genet 25: 144-146, 2000. (Pubitemid 30394982)
46. Anderson MG, Nakane M, Ruan X, Kroeger PE and Wu-Wong JR. Expression of VDR and CYP24A1 mRNA in human tumours. Cancer Chemother Pharmacol 57: 234-240, 2006. (Pubitemid 41779843)
47. Weiss MM, Snijders AM, Kuipers EJ, Ylstra B, Pinkel D, Meuwissen SG, van Diest PJ, Albertson DG and Meijer GA: Determination of amplicon boundaries at 20q13.2 in tissue samples of human gastric adenocarcinomas by high-resolution microarray comparative genomic hybridization. J Pathol 200: 320-326, 2003. (Pubitemid 36827306)
48. Friedrich M, Rafi L, Mitschele T, Tilgen W, Schmidt W and Reichrath J: Analysis of the vitamin D system in cervical carcinomas, breast cancer and ovarian cancer. Recent Results Cancer Res 164: 239-246, 2003.